A Phase 2 interventional study of salmeterol xinafoate, fluticasone propionate and Placebo in Abdominal Contour Defects, sponsored by Neothetics, Inc. Completed at 6 sites in United States. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-03-26.
Sponsored by Neothetics, Inc · Phase 2, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Dose ranging study
11,556 studies on the registry are indexed under Obesity; 2,055 are open to participants now.
This study's enrollment of 200 is above the median of 67 across 9,036 interventional studies indexed under Obesity.
Browse Obesity studies →Neothetics, Inc is the lead sponsor of 11 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Drug: salmeterol xinafoate, fluticasone propionate
Drug: salmeterol xinafoate, fluticasone propionate
Drug: salmeterol xinafoate, fluticasone propionate
Drug: Placebo
Drug: salmeterol xinafoate
Drug pages: Salmeterol Xinafoate · Fluticasone
LIPO-102
Also known as: LIPO-102
Placebo
Salmeterol
Safety
physical exam, vital signs, clinical assessment of injection, clinical laboratory tests, and adverse events
Time frame: 8 weeks treatment
Change in abdominal circumference
abdominal circumference
Time frame: Baseline to 9 weeks
Change in global clinician scale score
Time frame: Baseline to 9 weeks
Change in global patient scale score
Time frame: Baseline to 9 weeks
Change in Photonumeric scale score
Time frame: Baseline to 9 weeks
Change in Patient Reported Outcome Score
Time frame: Baseline to 9 weeks
The record gives a start of Aug 2011, a primary completion of Oct 2012 and a completion of Oct 2012. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Salmeterol Xinafoate · Fluticasone
Neothetics, Inc